By acquiring T3 Pharma, a leader in bacterial cancer treatment, Boehringer Ingelheim broadens its offering in immunooncology.

Published Date: 27 Nov 2023

Germany: T3 Pharmaceuticals AG, a privately held clinical stage Swiss biotech company, has been acquired by Boehringer Ingelheim for an $.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The main subject is associated with suicide in the United States.

2.

Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.

3.

Aspirin Fails to Boost Survival in Colorectal Cancer Trial

4.

The combination of nitedanib and prednisone reduces exacerbations of pulmonary diseases in radiative pneumonitis

5.

Immunotherapy in Head and Neck Cancer After Failure of Definitive Therapy.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot